UNSPSC 85613413: Revision of autologous tissue substitute in pancreatic duct, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in pancreatic duct, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FWD77Z

UNSPSC 85613413 Revision of autologous tissue substitute in pancreatic duct, via natural or artificial opening is a Commodity code that shows no relevant recent state and local procurement activity. The code describes a highly specialized surgical procedure involving pancreatic duct tissue revision, but the available recent opportunities are unrelated — they include independent medical evaluation services for public-safety pension boards, surgical benefit carve-out programs for municipal employees, occupational medical surveillance for ferry workers, emergency healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve pancreatic duct revision or autologous tissue substitution, and the mismatch suggests either misclassification in the state and local systems or that this code sees little to no actual procurement activity at the state or local level.

Without verifiable recent opportunities in the UNSPSC 85613413 scope, state and local governments do not appear to be actively procuring this procedure through standard public contracting channels. Firms evaluating this code should assess whether it reflects an operational gap in state and local health procurement taxonomies, or whether such specialized surgical services are procured through different mechanisms — such as specialty networks embedded in larger health plan contracts, direct provider relationships, or federal purchasing vehicles — rather than as discrete public solicitations.